1.Lower plasma selenoprotein P levels in regularly exercising young adults
Swe Mar Oo ; Min Thar Htut ; Ye Win Htun ; Aye Aye Mon ; May Pyone Kyaw
Journal of the ASEAN Federation of Endocrine Societies 2023;38(S1):6-12
Objective:
Physical exercise can provide many health benefits in humans. Exercise-induced reactive oxygen species (ROS) formation and its downstream signaling cascades are reported to induce mitochondrial biogenesis in exercising tissues. Selenoprotein P (SELENOP) is the antioxidant hepatokine whose hypersecretion is associated with various metabolic diseases. It was reported to impair exercise-induced reactive oxygen species signaling and inhibit subsequent mitochondrial biogenesis in mice. However, the relationship between selenoprotein P and mitochondrial dynamics in humans has not yet been reported. While reduction of plasma selenoprotein P becomes an attractive therapeutic target for metabolic diseases, the role of regular exercise in this regard is still unknown. This study aimed to analyze the influence of regular habitual exercise on plasma selenoprotein P levels and its association with leucocyte mitochondrial DNA copy number in healthy young adults.
Methodology:
Plasma selenoprotein P levels and leucocyte mitochondrial DNA copy numbers were compared in 44 regularly exercising subjects and 44 non-exercising controls, and the correlation between the two parameters was
analyzed. Plasma selenoprotein P levels were measured by Enzyme-linked Immunosorbent Assay, and leucocyte
mitochondrial DNA copy numbers were measured using the qPCR method.
Results:
The regular-exercise group had lower plasma selenoprotein P levels with higher leucocyte mitochondrial DNA copy numbers than the non-exercise group. There was a tendency of negative correlation between the two variables in our studied population.
Conclusion
Regular habitual exercise has a beneficial effect on reducing plasma selenoprotein P levels while raising mitochondrial DNA copy numbers.
mitochondria
;
physical exercise
;
reactive oxygen species
;
selenoprotein P
2.Hepatokines as a Link between Obesity and Cardiovascular Diseases.
Diabetes & Metabolism Journal 2015;39(1):10-15
Non-alcoholic fatty liver disease, which is considered a hepatic manifestation of metabolic syndrome, independently increases the risks of developing cardiovascular disease (CVD) and type 2 diabetes mellitus. Recent emerging evidence suggests that a group of predominantly liver-derived proteins called hepatokines directly affect the progression of atherosclerosis by modulating endothelial dysfunction and infiltration of inflammatory cells into vessel walls. Here, we summarize the role of the representative hepatokines fibroblast growth factor 21, fetuin-A, and selenoprotein P in the progression of CVD.
alpha-2-HS-Glycoprotein
;
Atherosclerosis
;
Cardiovascular Diseases*
;
Diabetes Mellitus, Type 2
;
Fatty Liver
;
Fibroblast Growth Factors
;
Obesity*
;
Selenoprotein P
3.Increased Selenoprotein P Levels in Subjects with Visceral Obesity and Nonalcoholic Fatty Liver Disease.
Hae Yoon CHOI ; Soon Young HWANG ; Chang Hee LEE ; Ho Cheol HONG ; Sae Jeong YANG ; Hye Jin YOO ; Ji A SEO ; Sin Gon KIM ; Nan Hee KIM ; Sei Hyun BAIK ; Dong Seop CHOI ; Kyung Mook CHOI
Diabetes & Metabolism Journal 2013;37(1):63-71
BACKGROUND: Selenoprotein P (SeP) has recently been reported as a novel hepatokine that regulates insulin resistance and systemic energy metabolism in rodents and humans. We explored the associations among SeP, visceral obesity, and nonalcoholic fatty liver disease (NAFLD). METHODS: We examined serum SeP concentrations in subjects with increased visceral fat area (VFA) or liver fat accumulation measured with computed tomography. Our study subjects included 120 nondiabetic individuals selected from participants of the Korean Sarcopenic Obesity Study. In addition, we evaluated the relationship between SeP and cardiometabolic risk factors, including homeostasis model of insulin resistance (HOMA-IR), high sensitivity C-reactive protein (hsCRP), adiponectin values, and brachial-ankle pulse wave velocity (baPWV). RESULTS: Subjects with NAFLD showed increased levels of HOMA-IR, hsCRP, VFA, and several components of metabolic syndrome and decreased levels of adiponectin and high density lipoprotein cholesterol than those of controls. Serum SeP levels were positively correlated with VFA, hsCRP, and baPWV and negatively correlated with the liver attenuation index. Not only subjects with visceral obesity but also those with NAFLD exhibited significantly increased SeP levels (P<0.001). In multiple logistic regression analysis, the subjects in the highest SeP tertile showed a higher risk for NAFLD than those in the lowest SeP tertile, even after adjusting for potential confounding factors (odds ratio, 7.48; 95% confidence interval, 1.72 to 32.60; P=0.007). CONCLUSION: Circulating SeP levels were increased in subjects with NAFLD as well as in those with visceral obesity and may be a novel biomarker for NAFLD.
Adiponectin
;
C-Reactive Protein
;
Cholesterol
;
Cholesterol, HDL
;
Energy Metabolism
;
Fatty Liver
;
Homeostasis
;
Humans
;
Insulin Resistance
;
Intra-Abdominal Fat
;
Lipoproteins
;
Liver
;
Logistic Models
;
Obesity
;
Obesity, Abdominal
;
Pulse Wave Analysis
;
Risk Factors
;
Rodentia
;
Selenoprotein P
;
Selenoproteins
4.Exendin-4 Inhibits the Expression of SEPP1 and Fetuin-A via Improvement of Palmitic Acid-Induced Endoplasmic Reticulum Stress by AMPK.
Jinmi LEE ; Seok Woo HONG ; Se Eun PARK ; Eun Jung RHEE ; Cheol Young PARK ; Ki Won OH ; Sung Woo PARK ; Won Young LEE
Endocrinology and Metabolism 2015;30(2):177-184
BACKGROUND: Selenoprotein P (SEPP1) and fetuin-A, both circulating liver-derived glycoproteins, are novel biomarkers for insulin resistance and nonalcoholic fatty liver disease. However, the effect of exendin-4 (Ex-4), a glucagon-like peptide-1 receptor agonist, on the expression of hepatokines, SEPP1, and fetuin-A, is unknown. METHODS: The human hepatoma cell line HepG2 was treated with palmitic acid (PA; 0.4 mM) and tunicamycin (tuni; 2ug/ml) with or without exendin-4 (100 nM) for 24 hours. The change in expression of PA-induced SEPP1, fetuin-A, and endoplasmic reticulum (ER) stress markers by exendin-4 treatment were evaluated using quantitative real-time reverse transcription polymerase chain reaction and Western blotting. Transfection of cells with AMP-activated protein kinase (AMPK) small interfering RNA (siRNA) was performed to establish the effect of exendin-4-mediated AMPK in the regulation of SEPP1 and fetuin-A expression. RESULTS: Exendin-4 reduced the expression of SEPP1, fetuin-A, and ER stress markers including PKR-like ER kinase, inositol-requiring kinase 1alpha, activating transcription factor 6, and C/EBP homologous protein in HepG2 cells. Exendin-4 also reduced the expression of SEPP1 and fetuin-A in cells treated with tunicamycin, an ER stress inducer. In cells treated with the AMPK activator 5-aminoidazole-4-carboxamide ribonucleotide (AICAR), the expression of hepatic SEPP1 and fetuin-A were negatively related by AMPK, which is the target of exendin-4. In addition, exendin-4 treatment did not decrease SEPP1 and fetuin-A expression in cells transfected with AMPK siRNA. CONCLUSION: These data suggest that exendin-4 can attenuate the expression of hepatic SEPP1 and fetuin-A via improvement of PA-induced ER stress by AMPK.
Activating Transcription Factor 6
;
alpha-2-HS-Glycoprotein*
;
AMP-Activated Protein Kinases*
;
Blotting, Western
;
Carcinoma, Hepatocellular
;
Cell Line
;
Endoplasmic Reticulum
;
Endoplasmic Reticulum Stress*
;
Fatty Liver
;
Glucagon-Like Peptide 1
;
Glycoproteins
;
Hep G2 Cells
;
Humans
;
Insulin Resistance
;
Palmitic Acid
;
Phosphotransferases
;
Polymerase Chain Reaction
;
Reverse Transcription
;
RNA, Small Interfering
;
Selenoprotein P
;
Transfection
;
Tunicamycin
;
Biomarkers
;
Glucagon-Like Peptide-1 Receptor
5.The apoptosis-inducing activity of human selenoprotein P shorter isoform.
Qing FANG ; Yao YI ; Yan-hua ZHENG ; Quan CHEN ; Li NING ; Yuan-yuan ZHA ; Sheng-li BI ; Jian-guo YANG ; Chen LIN
Chinese Journal of Oncology 2004;26(11):652-656
<p>OBJECTIVEHuman selenoprotein P (HSelP) is unique protein that contains 10 selenocysteines encoded by 10 inframe UGA, which typically function as stop codon. The function of HSelP remains unclear, in part due to the inability to express it by gene recombinant technique. This study is to investigate expression and purification of recombinant HSelP in prokaryotic expression system, and its activity to induce apoptosis in vitro.p><p>METHODSThe shorter HSelP isoform was cloned. After the selenocysteine (SeCys) at 40th position from N terminus of the HSelP shorter isoform was mutated into cysteine by PCR, it was expressed in E. coli. The expressed product was purified with DEAE column and identified by Western blot. Subsequently, its function on induction of mitochondrial apoptotic activity was studied.p><p>RESULTSThe mutant HSelP shorter isoform expressed in prokaryotic system was purified by DEAE column to 90% homogeneity. The purified product, HSelP280m, induced the opening of mitochondrial permeability transition pore (PTP) and decreased the transmembrane potential in a dose-dependent manner. These events could be abolished by PTP specific inhibitors.p><p>CONCLUSIONHSelP280m can induce the opening of mitochondrial PTP, which provides a basis for investigating the structure and function of recombinant HSelP.p>
Animals
;
Apoptosis
;
drug effects
;
Cloning, Molecular
;
Cysteine
;
genetics
;
Escherichia coli
;
metabolism
;
Humans
;
Ion Channels
;
drug effects
;
Male
;
Membrane Potentials
;
drug effects
;
Mice
;
Mice, Inbred BALB C
;
Mitochondria, Liver
;
physiology
;
Mitochondrial Membrane Transport Proteins
;
Mutation
;
Protein Isoforms
;
Proteins
;
genetics
;
metabolism
;
pharmacology
;
Selenium
;
Selenocysteine
;
genetics
;
Selenoprotein P
;
Selenoproteins